Delta 9 Cannabis Inc. (DLTNF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Delta 9 Cannabis Inc. (DLTNF) es una empresa del sector Healthcare valorada en 0. Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Delta 9 Cannabis Inc. (DLTNF) Resumen de Asistencia Médica y Tuberías
Delta 9 Cannabis Inc. is a Canadian integrated cannabis company involved in cultivation, processing, distribution, and retail. With 35 retail stores across the Canadian Prairies, Delta 9 offers a range of cannabis products, including dried flowers, oils, and derivative products, catering to both medical and recreational markets.
Tesis de Inversión
Delta 9 Cannabis Inc. presents a speculative investment opportunity in the evolving Canadian cannabis market. The company's integrated business model, encompassing cultivation, processing, distribution, and retail, offers potential for revenue generation across the value chain. However, with a negative profit margin of -24.6% and a negative gross margin of -3.4%, the company's profitability is a concern. Future growth hinges on expanding retail operations, optimizing production costs, and capitalizing on emerging cannabis product trends. Investors should closely monitor the company's ability to achieve profitability and navigate the competitive landscape. The company's P/E ratio is -0.05.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Delta 9 Cannabis Inc. operates as an integrated cannabis company, participating in cultivation, processing, distribution, and retail sales.
- The company owns and operates 35 retail stores under the Delta 9 brand name across the Canadian Prairies as of April 20, 2022.
- Delta 9's product portfolio includes dried cannabis flowers, pre-rolls, oils, and extracted products, catering to both medical and recreational markets.
- The company has a negative profit margin of -24.6% and a negative gross margin of -3.4%, indicating profitability challenges.
- Delta 9's beta of 1.13 suggests that the stock is more volatile than the market average.
Competidores y Pares
Fortalezas
- Integrated operations across the cannabis value chain.
- Established retail presence in the Canadian Prairies.
- Proprietary grow pod technology.
- Delta 9 brand recognition.
Debilidades
- Negative profit margin and gross margin.
- Limited geographic presence compared to larger competitors.
- Reliance on the Canadian cannabis market.
- Small market capitalization.
Catalizadores
- Ongoing: Expansion of retail operations to new locations.
- Ongoing: Development and launch of new cannabis products.
- Ongoing: Potential changes in cannabis regulations in Canada.
- Upcoming: Announcement of strategic partnerships or acquisitions.
- Upcoming: Positive financial results demonstrating improved profitability.
Riesgos
- Ongoing: Intense competition in the Canadian cannabis market.
- Ongoing: Evolving regulations and compliance requirements.
- Potential: Fluctuations in cannabis prices affecting revenue.
- Potential: Economic downturn reducing consumer spending on cannabis.
- Potential: Delays in regulatory approvals for new products or expansion plans.
Oportunidades de crecimiento
- Expansion of Retail Footprint: Delta 9 can expand its retail presence beyond the Canadian Prairies to other provinces, increasing its market reach and revenue potential. The Canadian cannabis retail market is projected to reach several billion dollars in the coming years, offering significant growth opportunities for companies with established retail networks. The timeline for expansion depends on regulatory approvals and capital availability.
- Product Innovation and Diversification: Delta 9 can invest in research and development to create new and innovative cannabis products, catering to evolving consumer preferences. This includes developing new formulations, delivery methods, and product formats. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly, presenting opportunities for Delta 9 to diversify its product portfolio. The timeline for product development and launch is typically 12-18 months.
- Strategic Partnerships and Acquisitions: Delta 9 can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, or research institutions. Acquisitions can provide access to new markets, technologies, or product lines. The timeline for partnerships and acquisitions varies depending on the specific opportunities.
- International Expansion: Delta 9 can explore opportunities to expand its operations internationally, particularly in countries with legal cannabis markets. This includes exporting cannabis products, establishing joint ventures, or acquiring foreign cannabis companies. The global cannabis market is growing rapidly, offering significant long-term growth potential. The timeline for international expansion depends on regulatory approvals and market conditions.
- Medical Cannabis Focus: Delta 9 can focus on expanding its medical cannabis business, catering to patients seeking cannabis-based therapies. This includes developing new medical cannabis products, partnering with healthcare providers, and conducting clinical research. The medical cannabis market is growing steadily, driven by increasing awareness of the therapeutic benefits of cannabis. The timeline for medical cannabis initiatives depends on regulatory approvals and clinical trial results.
Oportunidades
- Expansion of retail footprint to other provinces.
- Product innovation and diversification.
- Strategic partnerships and acquisitions.
- International expansion.
Amenazas
- Increasing competition in the Canadian cannabis market.
- Evolving regulations and compliance requirements.
- Fluctuations in cannabis prices.
- Economic downturn affecting consumer spending.
Ventajas competitivas
- Integrated operations provide control over the entire value chain.
- Established retail presence in the Canadian Prairies.
- Proprietary grow pod technology.
- Delta 9 brand recognition.
Acerca de DLTNF
Delta 9 Cannabis Inc., incorporated in 2001 and headquartered in Winnipeg, Canada, operates as an integrated cannabis company. Through its subsidiary, Delta 9 Bio-Tech Inc., the company cultivates, processes, extracts, and distributes cannabis products. Delta 9's operations span the entire cannabis value chain, from cultivation to retail sales. The company's product portfolio includes dried cannabis flowers, pre-rolls, decontamination pods, dried sift cannabis, oils, and extracted and derivative products. Delta 9 also provides grow pods and live plants to other licensed and pre-licensed cannabis companies. In addition to its product offerings, Delta 9 operates a medical clinic providing physician consultation services for patients seeking medical cannabis prescriptions. As of April 20, 2022, Delta 9 owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies, solidifying its presence in the regional cannabis market. Delta 9 continues to expand its retail footprint and product offerings to meet the evolving demands of the cannabis market.
Qué hacen
- Cultivates cannabis plants in controlled environments.
- Processes raw cannabis into various product forms.
- Extracts cannabinoids to create oils and concentrates.
- Wholesales cannabis products to other licensed retailers.
- Operates retail stores under the Delta 9 brand.
- Sells medical and recreational cannabis products.
- Provides physician consultation services for medical cannabis prescriptions.
Modelo de Negocio
- Vertically integrated operations from cultivation to retail.
- Revenue generation through wholesale and retail sales of cannabis products.
- Medical clinic services providing cannabis prescriptions.
- Sales of grow pods and live plants to other licensed producers.
Contexto de la Industria
Delta 9 Cannabis Inc. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing competition, evolving regulations, and shifting consumer preferences. Delta 9 competes with other licensed producers and retailers, vying for market share in both the medical and recreational cannabis segments. The Canadian cannabis market is expected to continue growing, driven by increasing legalization and acceptance of cannabis products. Companies like Delta 9 must adapt to changing regulations and consumer demands to remain competitive.
Clientes Clave
- Recreational cannabis consumers.
- Medical cannabis patients with prescriptions.
- Other licensed cannabis retailers (wholesale).
- Licensed and pre-licensed cannabis companies (grow pods and live plants).
Finanzas
Gráfico e información
Precio de la acción de Delta 9 Cannabis Inc. (DLTNF): Price data unavailable
Últimas noticias
-
Cannabis and Crypto Joins Forces?
benzinga · 18 ene 2022
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DLTNF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para DLTNF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de DLTNF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: John William Arbuthnot IV
CEO
John William Arbuthnot IV serves as the CEO of Delta 9 Cannabis Inc. His leadership is pivotal in guiding the company's strategic direction and operational execution. Information regarding his specific educational background and previous roles is not available. As CEO, he is responsible for overseeing all aspects of the company's operations, including cultivation, processing, distribution, and retail sales. He manages a workforce of approximately 200 employees.
Historial: Under John William Arbuthnot IV's leadership, Delta 9 Cannabis Inc. has expanded its retail footprint to 35 stores across the Canadian Prairies. He has overseen the development and launch of new cannabis products and the implementation of the company's integrated business model. However, the company's financial performance has been challenged by negative profit margins.
Información del mercado OTC de DLTNF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Delta 9 Cannabis Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Lower trading volumes and liquidity.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volumes and price movements.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Licensed cannabis producer and retailer in Canada.
- Operational retail stores under the Delta 9 brand.
- Presence in the cannabis industry since 2001.
- Integrated operations across the cannabis value chain.
Preguntas Comunes Sobre DLTNF
¿Cuáles son los factores clave para evaluar DLTNF?
Delta 9 Cannabis Inc. (DLTNF) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Integrated operations across the cannabis value chain.. Riesgo principal a monitorear: Ongoing: Intense competition in the Canadian cannabis market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de DLTNF?
DLTNF actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de DLTNF?
Los precios de DLTNF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre DLTNF?
La cobertura de analistas para DLTNF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en DLTNF?
Las categorías de riesgo para DLTNF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the Canadian cannabis market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de DLTNF?
La relación P/E para DLTNF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está DLTNF sobrevalorada o infravalorada?
Determinar si Delta 9 Cannabis Inc. (DLTNF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de DLTNF?
Delta 9 Cannabis Inc. (DLTNF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited.
- OTC stocks are inherently riskier than exchange-listed stocks.